Table 4.
Drug | IC50, μM (pIC50, M) | *IC50, μM (pIC50, M) | Hill Coeff |
---|---|---|---|
Amiloride | |||
Control | 0.75 (−6.12±0.08) | 1.03 (−5.99±0.11) | 1.39 |
Dex | 0.68 (−6.17±0.14) | 0.89 (−6.05±0.06) | 0.92 |
Benzamil | |||
Control | 0.10 (−7.01±0.16) | 0.20 (−6.68±0.25) | 0.90 |
Dex | 0.09 (−7.05±0.10) | 0.10 (−7.01±0.11) | 1.00 |
EIPA | |||
Control | 20.8 (−4.68±0.24) | 0.79 | |
Dex | 47.5 (−4.32±0.44) | 0.73 |
Values are means ± SE (n = 5 for each drug). IC50, concentration required to produce half-maximal current density inhibition. Cont, control incubation without dexamethasone; Dex, incubation with dexamethasone.
IC50 from fit to Hill equation with residual current during maximal inhibition by drug (Ioffset) = 0.